Metric Finance
LearnFAQ
LearnFAQ

Learn / STVN

NYSE: STVN

Stevanato Group S.p.A. (STVN) stock, explained like you're 5

Stevanato Group S.p.A. trades on the New York Stock Exchange under the ticker STVN. It is a mid cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 5.3 billion dollars.

Ticker
STVN
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Medical/Dental Instruments
Size
Mid cap, about 5.3 billion dollars

Is Stevanato Group S.p.A. a small, medium or large cap company?

No. Stevanato Group S.p.A. is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 5.3 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Stevanato Group S.p.A. makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves STVN stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Stevanato Group S.p.A. $STVN Stock Sold by Cooper Investors PTY Ltd. (MarketBeat)
  • Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings (Yahoo Finance)
  • (STVN) Risk Channels and Responsive Allocation (Stock Traders Daily)
  • Stevanato Group (STVN) Edges Lower to $19.20 as Shares Consolidate Below Resistance Seasonality Effect (https://www.siam.in/)
  • Stevanato Group S.p.A. (STVN) Stock Price: Oct 15 Close $19.25 (Gotrade)

Follow STVN in your daily brief

Each trading day at 5 PM ET we post what happened to Stevanato Group S.p.A. and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow STVN

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Stevanato Group S.p.A. stock

What does Stevanato Group S.p.A. do?

Stevanato Group S.p.A. trades on the New York Stock Exchange under the ticker STVN. It is a mid cap company in the medical/dental instruments industry, part of the healthcare sector, with a market value of about 5.3 billion dollars.

What is the ticker symbol for Stevanato Group S.p.A.?

Stevanato Group S.p.A. trades under the ticker STVN on the New York Stock Exchange.

What is Stevanato Group S.p.A.'s market cap?

Stevanato Group S.p.A. is a mid cap stock with a market cap of about 5.3 billion dollars.

How does Stevanato Group S.p.A. make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves STVN stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow STVN stock every day?

Add STVN to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow STVN daily

A free brief on Stevanato Group S.p.A. and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • SYK · Stryker
  • BDX · Becton Dickinson & co
  • MDLN · Medline
  • RMD · Resmed

Similar stocks

  • SYKStryker
  • BDXBecton Dickinson & co
  • MDLNMedline
  • RMDResmed

Compare STVN: STVN vs SYK, STVN vs BDX, STVN vs MDLN

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed